Evidence map›Paper›PMID 35431302›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Clinicopathological Characteristics of Superficial Barrett's Adenocarcinoma in a Japanese Population: A Retrospective, Multicenter Study.

Kenta Hamada, Hiromitsu Kanzaki, Koji Miyahara, Masahiro Nakagawa, Hirokazu Mouri, Motowo Mizuno, Sakuma Takahashi, Shinichiro Hori, Junichiro Nasu, Takao Tsuzuki and 16 more

Open access · diamondAbstract readMulticenter Study
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Guideline
  2. Article
  3. Article
  4. Article
  5. Evolution of Treatment Outcomes and Prognostic Factors in Esophageal Cancer Surgery: A Retrospective Analysis of 1500 Consecutive Esophagostomies.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 15 institutions in 1 country.

Kenta HamadaDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Hiromitsu KanzakiDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Koji MiyaharaDepartment of Internal Medicine, Hiroshima City Hospital, Japan.
Masahiro NakagawaDepartment of Internal Medicine, Hiroshima City Hospital, Japan.
Hirokazu MouriDepartment of Gastroenterology and Hepatology, Kurashiki Central Hospital, Japan.
Motowo MizunoDepartment of Gastroenterology and Hepatology, Kurashiki Central Hospital, Japan.
Sakuma TakahashiDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Japan.
Shinichiro HoriDepartment of Endoscopy, National Hospital Organization Shikoku Cancer Center, Japan.
Junichiro NasuDepartment of Internal Medicine, Okayama Saiseikai General Hospital, Japan.
Takao TsuzukiDepartment of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Japan.
Jiro MiyaikeDepartment of Internal Medicine, Saiseikai Imabari Hospital, Japan.
Ryuta TakenakaDepartment of Internal Medicine, Tsuyama Chuo Hospital, Japan.
Kenji YamauchiDepartment of Gastroenterology, Mitoyo General Hospital, Japan.
Sayo KobayashiDepartment of Internal Medicine, Fukuyama City Hospital, Japan.
Tatsuya ToyokawaDepartment of Gastroenterology, National Hospital Organization Fukuyama Medical Center, Japan.
Masafumi InoueDepartment of Gastroenterology, Japanese Red Cross Okayama Hospital, Japan.
Mamoru NishimuraDepartment of Internal Medicine, Okayama City Hospital, Japan.
Minoru MatsubaraDepartment of Internal Medicine, Sumitomo Besshi Hospital, Japan.
Jun TomodaDepartment of Internal Medicine, Akaiwa Medical Association Hospital, Japan.
Yasushi YamasakiDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Takehiro TanakaDepartment of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Yasuhiro ShirakawaDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Yoshiro KawaharaDepartment of Practical Gastrointestinal Endoscopy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Toshiyoshi FujiwaraDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Hiroyuki OkadaDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Okayama Gut Study Group
Okayama University · JPKurashiki Central Hospital · JPFukuyama Cardiovascular Hospital · JPFukuyama City Hospital · JPHimeji Red Cross Hospital · JPJapan Medical Association · JPKagawa Prefectural Central Hospital · JPMito Saiseikai General Hospital · JPOkayama Prefecture · JPOkayama Red Cross General Hospital · JPOkayama Saiseikai General Hospital · JPSaiseikai Ibaraki Hospital · JPShikoku Cancer Center · JPSumitomo Besshi Hospital · JPTsuyama Chuo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Although Barrett's adenocarcinoma (BA) remains a minor disease in Japan, its incidence has been gradually increasing. We analyzed the characteristics of BA in Japanese populations. Methods We retrospectively reviewed medical records and analyzed the clinicopathological differences between short-segment Barrett's esophagus (SSBE) and long-segment Barrett's esophagus (LSBE), as well as metastasis. Local recurrence and metachronous lesions were analyzed only in patients who underwent endoscopic resection (ER). Patients Consecutive patients who had pathological T1 BAs resected by ER or surgery from January 2003 to December 2017. Results A total of 168 patients were analyzed, including 139 with SSBE and 29 with LSBE. In total, 67% of the SSBE lesions and 32% of the LSBE lesions were located between 0 and 3 o'clock (p=0.0014). No patients who achieved pathological margin-free resection (pR0) and 17% of patients who did not achieve pR0 experienced local recurrence (p=0.0131). None of the patients without lymphovascular involvement, a poorly differentiated component, lesion size of >30 mm, and submucosal invasion of >500 μm experienced metastasis. The 5-year cumulative incidence rate of metachronous BA after ER was 0% in patients with SSBE and 40% in patients with LSBE (p=0.0005). Conclusion Superficial BA was likely to be detected at the right anterior wall of SSBE in the Japanese population. The risk for metachronous BA after ER was high in Japanese patients with LSBE, as in Western patients.

Indexed as

AdenocarcinomaBarrett EsophagusEsophageal NeoplasmsHumansJapanRetrospective StudiesBarrett's adenocarcinomaendoscopic resectionlong-segment Barrett's esophagusmetachronous lesionshort-segment Barrett's esophagussurgery

Identifiers

PMID35431302
PMCPMC9107981
OpenAlexW4224002513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.